Uncovering Institutional Buying In Boston Scientific Corp. (NYSE: BSX)

Currently, there are 1.47B common shares owned by the public and among those 1.46B shares have been available to trade. The company’s stock has a 5-day price change of 0.44% and 21.47% over the past three months. BSX shares are trading 17.26% year to date (YTD), with the 12-month market performance up to 41.38% higher. […]

Boston Scientific Corp. (NYSE: BSX): The Best-Of-Breed For Investing?

Currently, there are 1.47B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 77 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 44 of these insider trades were purchases, […]

Assessing Whether Boston Scientific Corp. (NYSE: BSX) Is Over- Or Undervalued

Boston Scientific Corp. (BSX) concluded trading on Wednesday at a closing price of $66.99, with 4.74 million shares of worth about $317.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.54% during that period and on on Wednesday the price saw a gain […]

Boston Scientific Corp. (NYSE: BSX) Has Another Chance To Impress You

Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 106 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 58 of these insider trades were purchases, […]

Value Hunters: Look To Boston Scientific Corp. (BSX)

Currently, there are 1.46B common shares owned by the public and among those 1.46B shares have been available to trade. Insiders at the company have transacted a total of 190 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 98 of these insider trades were purchases, […]

Boston Scientific Corp. (BSX): A Great Stock For Handling Current Market Conditions?

The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.81 billion. In addition, […]

Boston Scientific Corp. (NYSE: BSX): Hunting Genuine Value In Market Debris

The Vanguard Group, Inc. recently announced the acquisition of new stake in Boston Scientific Corp. (NYSE:BSX). The institutional investor has increased its shareholding in the Healthcare company by 1.20% to 117.78 million shares with purchase of 1.4 million shares. This fresh investment now brings its stake to 8.04% valued currently at $6.81 billion. In addition, […]